Therapeutically-induced stable disease in oncology early clinical trials

RATIONALE: The RECIST guideline defines four categories of response to treatment for cancer patients according to post-baseline changes in tumor burden, hence ignoring disease history. However, if left untreated, tumors grow exponentially, implying that pretreatment changes in tumor size are key to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercier, Francois, Meneses-Lorente, Georgina, Grimsey, Paul, Phipps, Alex, Michielin, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259628/
https://www.ncbi.nlm.nih.gov/pubmed/32470048
http://dx.doi.org/10.1371/journal.pone.0233882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259628/
https://www.ncbi.nlm.nih.gov/pubmed/32470048
http://dx.doi.org/10.1371/journal.pone.0233882

Ejemplares similares